Ahmed Elkhanany

Dr. Ahmed Elkhanany is an Assistant Professor of Medicine at the Lester and Sue Smith Breast Center within Baylor College of Medicine. He is board-certified in internal medicine, hematology, and oncology, with clinical expertise in breast cancer prevention, hereditary risk assessment, and metastatic disease management.

• MD, Alexandria University School of Medicine (2011)
• Residency, University of Missouri-Kansas City (2016)
• Fellowship, Roswell Park Comprehensive Cancer Center (2019)
• Postdoctoral Fellowship, Mayo Clinic (2013)
• Triple Negative BC Graduate Certificate, Harvard Business School (2024)

His research focuses on translational breast cancer genomics, examining how race and ethnicity influence gene drivers. He develops novel lab-to-clinic treatment combinations and studies health disparities in underserved populations. A 2023 meta-analysis on homologous recombination mutations and 2021 work on CD8+ T-cell exhaustion in Black women highlight his genomic and immunologic expertise.

Recent publications include 2024 work on equity in clinical trials (Clin Adv Hematol Oncol) and 2023 studies on ESR1 mutation therapies (Ann Oncol), MSI-H biomarkers (NPJ Breast Cancer), and LOH status in advanced BC (Cancers). His 2018 meta-analysis on breast angiosarcoma and 2019 work on TNBC histopathology further demonstrate his clinical research breadth.

Awards include:

• Arab America 40 Under 40 (2025)
• Baylor Best Medicine Faculty Research Mentor (2025)
• University of Alabama Fellow Champion (2023)
• Best Oncology Teacher at BCM (2024)

He serves on ASCO and ESMO, and his skills span hereditary BC genomics, clinical trial design, and Arabic language proficiency.